polycomplex gel for the treatment of intestinal / digestive tract diseases

摘要

The polycomplex gel for the treatment of intestinal / digestive tract diseases The invention relates to the chemical and pharmaceutical industry and consists of a rectal gel substance for the treatment of intestinal / digestive tract diseases including non-specific ulcerative colitis, disease. crohn's, fistulas, etc., and also complications during the course of treatment of said diseases. The invention provides an antimicrobial and antiprotozoal effect and has good penetration capabilities. The technical result achieved by carrying out the claimed invention is to increase the treatment effectiveness of noninfectious inflammatory bowel / digestive tract diseases and shorten the duration of treatment. said technical result is achieved by means of a poly complex gel for the treatment of intestinal / digestive tract diseases, said gel containing metronidazole and thymogen as the active substances and containing the following auxiliary substances, in composition and in the ratio between components. then in grams, with a total gel mass of 150 grams: metronidazole: 0,1 to 2 g; thymogen: 0.001 to 0.05 g; carbopol: 0.2 to 1.0 g; propylene glycol: 8.0 to 11.0 g; edta disodium salt: 0.001 to 0.08 g; propyl parahydroxybenzoate: 0.015 to 0.04 g; methyl parahydroxybenzoate: 0.035 to 0.08g; sodium hydroxide: an amount sufficient to produce the required ph; distilled water: the rest.